NCT07210632 2026-02-27Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)Vanderbilt-Ingram Cancer CenterPhase EARLY_PHASE1 Not yet recruiting38 enrolled